RecruitingNCT05386615

Post-Exablate Pregnancy Outcomes Registry Study: Exablate Treatment of Symptomatic Uterine Fibroids

Sponsor

InSightec

Enrollment

200 participants

Start Date

Feb 16, 2016

Study Type

OBSERVATIONAL

Conditions

Uterine Fibroid

Summary

The goal of this Registry Study is to capture clinical pregnancy outcomes and fibroid treatment background data for any subject post-Exablate treatment for their symptomatic fibroids.

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 50 Years

Interventions

DEVICEBody System - Functional

MR-Guided Focused Ultrasound

Locations(6)

UCLA

Los Angeles, California, United States

Stanford University

Stanford, California, United States

Mayo Clinic

Rochester, Minnesota, United States

Huashan Hospital Affiliated to Fudan University

Shanghai, China

Shanghai No. 1 Hospital

Shanghai, China

Shanghai No.1 Hospital

Shanghai, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05386615

Related Trials

The Impact of a Novel GnRH Antagonist With Add-back Therapy for Treatment of Uterine Fibroids and Endometriosis on Hemostasis Parameters

NCT071731271 location

Evaluation of Uterine Fibroids by CEUS and SHAPE Pre and Post UAE

NCT067050751 location

Bearing nsPVA Embolization for Uterine Artery Embolization (BETTER-UAE)

NCT061536671 location